Figure 2.
Sialylated O-glycoproteins protect chronic lymphocytic leukemia B cells from NK cell cytotoxicity. (A) Effects of sialidase or O-sialoglycoprotein endopeptidase (OSGP-EP) treatment of JVM-3 cells on NK cell cytotoxicity. JVM-3 cells were treated with sialidase or OSGP-EP and subjected to cytotoxicity assay using an NK-92 cell line expressing Siglec-7 (NK-92MI/S7). Both treatments made JVM-3 cells more sensitive to NK cell cytotoxicity. Cytotoxicity assays were conducted in technical triplicate and repeated several times, with consistent results. Representative results are shown (*P < 0.05, **P < 0.01, and ***P < 0.001; Student’s t test). Bars represent mean ± SD of technical triplicates. (B) Effect of benzyl-2-acetamido-2-deoxy-α-d-galactopyranoside (benzyl-α-GalNAc) treatment of JVM-3 on NK cell cytotoxicity. JVM-3 cells cultured in the presence of benzyl-α-GalNAc (72 h) were more sensitive to NK cell cytotoxicity. Cytotoxicity assays were conducted in technical triplicate and repeated several times, with consistent results. Representative results are shown (*P < 0.05, Student’s t test). Bars represent mean ± SD of technical triplicates.